Target intelligence / Profile preview

Collagen alpha chain (None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].)

Target
None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].
Molecular classification
Other (structural subunit of extracellular matrix proteins), Component of fibrillar protein family (when specified, e.g., "Type I collagen alpha chain"), Not a receptor, enzyme, transporter, or transcription factor
01

Overview

Collagen alpha chains are the individual polypeptide subunits that combine to form the characteristic triple-helical structure of collagen molecules, known as tropocollagen[3][8]. Each collagen triple helix is formed by either identical or distinct alpha chains, depending on the collagen type: for example, type I collagen consists of two alpha-1(I) chains and one alpha-2(I) chain, while type II collagen is made from three alpha-1(II) chains[1][5][8]. There are dozens of different collagen alpha chains encoded by separate genes (e.g., COL1A1, COL6A3), which assemble with strict specificity to form various collagen types throughout the body[3][8]. Collagen alpha chains play essential roles in tissue architecture, strength, elasticity, and development[1][3][4]. Some specific alpha chains, such as collagen alpha-3 (VI) chain, also have unique functions as disease biomarkers and regulators of cellular behavior, especially in cancer and fibrosis via secreted fragments like endotrophin[2][4]. However, the general term "collagen alpha chains" is too broad and unspecific to serve as a conventional drug target or molecular entity for therapeutic intervention[2][3][8].

Other names
Collagen alpha polypeptideCollagen alpha subunitPrecursor collagen chainCollagen α chaine.g., COL1A1 (collagen type I alpha 1 chain)COL6A3 (collagen type VI alpha 3 chain)
02

Mechanism of action

Not applicable (as "collagen alpha chains" is not a therapeutic target); in specific instances, drugs may degrade collagen fibrils or inhibit fibrosis through enzymatic mechanisms[1][2].

03

Biological functions

Structural support in extracellular matrix[1][3][7][8]Formation of collagen triple helix structure[5][8]Tissue strength and elasticity (as part of collagen)[3]Cell adhesion and migration (when referring to certain chains, e.g., alpha-3 (VI) via endotrophin in cancer)[2]Role in organ development (as part of collagen)[3][4]
04

Disease associations

Cancer (especially for COL6A3, alpha-3 (VI) chain, via endotrophin's role in tumor progression)[2]Fibrosis and tissue scarring (as part of general collagen involvement)[2][4]Connective tissue disorders (when mutations occur in specific alpha chains)[4]Inflammatory diseases (e.g., atopic dermatitis involving COL6A5)[4]Skeletal disorders (mutations in chains of types I, II, X, XXVII, etc.[4])Other (depends on the specific alpha chain — some are biomarkers in kidney disease, bone disorders, cartilage degeneration[4])
05

Safety considerations

None for "collagen alpha chains" as an isolated entity; general concerns for collagen-targeting drugs include immune reactions, excessive tissue breakdown, interference with tissue integrity, and impaired wound healing[2][4].Excessive degradation or modification of collagen (which involves its alpha chains) can lead to tissue weakness, scarring, or impaired organ function[1][3][4].
06

Interacting drugs

None specific for "collagen alpha chains" as a general entity; some drugs may interact with collagen (e.g., enzymatic collagenase, pepsin for research/clinical use[1]). Specific alpha chains (e.g., endpoints for anti-fibrotic therapies) may be assessed, but the alpha chain itself is not a drug target.
07

Biomarkers

Endotrophin (cleaved fragment of collagen alpha-3 (VI) chain, i.e., COL6A3, is a biomarker in cancer and metabolic diseases)[2]Type XXIV and type XXVII collagen alpha chains are markers of bone formation and cartilage calcification, respectively[4]

Beyond the preview

Go deeper on Collagen alpha chain (None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen alpha chain (None; scientific literature may use abbreviations such as COL1A1, COL1A2, COL6A3, etc. to name specific alpha chains, but for the general term "Collagen alpha chains," no standard abbreviation exists[2][3][8].).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call